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Abstract
Background: The common marmoset monkey (Callithrix jacchus), a small non-endangered New World primate native 
to eastern Brazil, is becoming increasingly used as a non-human primate model in biomedical research, drug development 
and safety assessment. In contrast to the growing interest for the marmoset as an animal model, the molecular tools for 
genetic analysis are extremely limited.
Results: Here we report the development of the first marmoset-specific oligonucleotide microarray (EUMAMA) 
containing probe sets targeting 1541 different marmoset transcripts expressed in hippocampus. These 1541 transcripts 
represent a wide variety of different functional gene classes. Hybridisation of the marmoset microarray with labelled RNA 
from hippocampus, cortex and a panel of 7 different peripheral tissues resulted in high detection rates of 85% in the 
neuronal tissues and on average 70% in the non-neuronal tissues. The expression profiles of the 2 neuronal tissues, 
hippocampus and cortex, were highly similar, as indicated by a correlation coefficient of 0.96. Several transcripts with a 
tissue-specific pattern of expression were identified. Besides the marmoset microarray we have generated 3215 ESTs 
derived from marmoset hippocampus, which have been annotated and submitted to GenBank [GenBank: EF2I4838 -  
EF2I5447, EH380242 -  EH382846].
Conclusion: We have generated the first marmoset-specific DNA microarray and demonstrated its use to characterise 
large-scale gene expression profiles of hippocampus but also of other neuronal and non-neuronal tissues. In addition, we 
have generated a large collection of ESTs of marmoset origin, which are now available in the public domain. These new 
tools will facilitate molecular genetic research into this non-human primate animal model.
Open Access
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Background
The com m on m arm oset m onkey (Callithrix jacobus), a 
small non-endangered New W orld prim ate native to  east­
ern Brazil, is becom ing increasingly used as a non-hum an  
prim ate m odel in  biom edical research, drug developm ent 
and safety assessment. N ot only their close genetic, phys­
iological and m etabolic similarity to  hum ans bu t also sev­
eral unique physiological differences betw een O ld W orld 
and New W orld prim ates, underlie its w idespread use as 
an anim al m odel in  studies involving aspects o f infectious 
disease, stem cell research, neural and  cognitive sciences, 
toxicology and drug developm ent and  reproductive b io l­
ogy. Moreover, its availability, size, ease o f  breeding in  
laboratory conditions and  its clear advantages over other 
non-hum an  prim ates in  term s o f anim al welfare, costs 
and practicality contribute to  its popularity as an attractive 
alternative to  other non-hum an  prim ate species such as 
the rhesus m acaque [1]. In contrast to the growing interest 
for the m arm oset as an  anim al m odel, the m olecular tools 
for genetic analysis are extremely limited.
Although a M arm oset Genom e Project was initiated in  
2004 and is ongoing [2], today there are still only very few 
mRNA sequences o f m arm oset origin available in  the 
public dom ain. To allow gene expression profiling o f dif­
ferent m arm oset organs and delineation o f complex b io ­
logical pathways, we have developed a marmoset-specific 
DNA microarray, called EUMAMA (EUropean MArmoset 
MicroArray) starting from  large scale EST sequencing of 
m arm oset transcripts to  generate the required sequence 
inform ation.
The m arm oset array is an  initiative w ith in  a European 
C om m ission-funded consortium  aim ed at investigating 
the long term  effects o f prenatal exposure to  glucocorti­
coids [3] (horm ones secreted by the adrenal cortex in  
response to  stress) in  a non-hum an  prim ate m odel. The 
w orking hypothesis o f  this consortium  is tha t excessive 
foetal exposure to glucocorticoid horm ones (GCs) exerts 
organisational effects on  the developm ent o f  a variety of 
target tissues resulting in  altered gene expression patterns 
tha t m ay persist th roughou t life. These 'program m ing' 
effects are believed to  shape vulnerability to  a variety of 
adult diseases including heart disease, diabetes, kidney 
failure and brain  disorders [4-8]. Since the effects o f pre­
natal GC exposure are so widespread, we chose to  initially 
focus on  the effects in  the brain  by using hippocam pal 
RNA as a source to  generate EST sequences o n  the m arm o­
set array. The hippocam pus is a brain  structure involved in  
learning and m em ory processes, m ood  and regulation of 
the stress response via the hypothalam ic-pituitary-adrenal 
axis. GCs are essential for norm al h ippocam pal develop­
m ent, exerting a wide spectrum  o f effects, resulting in  
altered structural plasticity and function [9-12]. Therefore, 
the obvious applicability o f the m arm oset microarray is to
study neuronal gene expression. However, we show here 
th a t the m icroarray can also be used to  generate expres­
sion profiles in  a w ide variety o f non-neuronal m arm oset 
tissues.
Besides the m arm oset m icroarray we have generated 3215 
ESTs derived from  m arm oset hippocam pus, w hich have 
been functionally annotated  and subm itted to  GenBank 
[GenBank: EF214838 -  EF215447, EH380242 -  
EH 382846]. These new tools will facilitate m olecular 
genetic research in to  this non-hum an  prim ate anim al 
m odel.
Results
M apping, annotation and submission o f  sequences to 
G enBank
A total o f 3441 high quality sequences (Phred score: 
Q15>600; 87.5% o f the sequences also passed the thresh­
old  o f Q20>600 bp; the overall m inim al Q20 score was 
429 bp) were selected for annotation  [13]. After removal 
o f  redundan t sequences, 3215 high quality un ique 3' EST 
sequences rem ained w hich were trim m ed to an  average 
length o f 678 bases. A nnotation  o f the EST dataset to  the 
RefSeq dataset o f hum an  genes allowed unam biguous 
assignm ent o f gene nam es for 2250 sequences. A rem ain­
ing 292 sequences could also be confidently assigned w ith 
gene nam es by m apping to  the hum an  genom e or cross­
species m apping. O f these 2542 (2250 + 292) sequences 
assigned w ith a gene nam e, 610 (19% ) sequences could 
also be annotated  w ith an open reading frame (ORF) (Fig­
ure 1A). These ORF-containing sequences were subm itted 
to  GenBank [GenBank: EF214838 -  EF215447]. The 
m ajority o f the rem aining 673 sequences w ithout an 
assigned gene nam e consisted o f a group o f  642 (20% ) 
w hich could n o t be m atched to  a know n mRNA b u t were 
m appable on  the genom e and 31 (1%) w hich could n o t 
m apped to  RefSeq genes nor to a m am m alian  genom e 
(Figure 1A). The latter 31 genes m ost likely represent 
novel genes tha t may be uniquely expressed in  the m ar­
m oset hippocam pus. All 2605 (81% ) EST sequences w ith­
ou t an  ORF were subm itted to  dbEST [GenBank: 
EH380242 -  EH 382846].
G ene selection and construction o f  the m arm oset  
m icroarray
A subset o f  1448 o f the annotated  3'ESTs were selected by 
the EUPEAH consortium  to be represented on  the m arm o­
set array, supplem ented w ith 68 m arm oset cDNA 
sequences available in  GenBank. We selected the Gene­
Chip® CustomExpress® Array Program o f Affymetrix for 
design and  m anufacturing o f the m arm oset array (form at 
100-2187 containing approx. 1,600 gene sequences a t 11 
probe pairs per probe set). This choice was based on  the 
previous experience o f Affymetrix working w ith consortia 
to  design specific dedicated arrays b u t also due to  the
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P ie charts. A: C om pos it ion  o f 3215 m arm ose t ESTs.
Pie chart indicating the composition of the 3215 marmoset 
ESTs derived from a normalized hippocampal cD N A  library. 
After mapping and annotation, a total of 1932 (60%) ESTs 
were assigned a gene name, 610 (19%) contained a partial 
ORF, 642 (20%) were mappable to a genome but could not 
be assigned a gene name and 31 (1%) could not be mapped. 
B: O rig in  o f m arm ose t sequences. Pie chart indicating 
the origin of the marmoset sequences represented on the 
marmoset microarray. O f the in total 1541 marmoset tran­
scripts represented on the array the majority (1445 = 95%) 
were derived from the set of 3215 marmoset ESTs submitted 
to GenBank. The remaining 5% consisted of 68 pre-existing 
marmoset sequences already present in GenBank and 28 
ESTs from the hippocampal cD NA  library that were not sub­
mitted to GenBank. The 1445 submitted ESTs could be sub­
divided into a group of 886 (58%) that were assigned a gene 
name, 364 (24%) with a (partial) ORF, 188 (12%) that were 
mappable but without a gene name or an ORF and 7 (0%) 
that were not mappable.
advantages of standardisation of the hybridisation and 
data extraction procedure. The sequence data was submit­
ted to the Affymetrix Chip Design Group and used to 
design 11 perfect match and mismatch 25-mer oligonu­
cleotides per sequence according to the standard algo­
rithms used in Affymetrix commercially available 
catalogue arrays. The most optimal probes sets per 
sequence were selected for in situ synthesis on the mar­
moset array. Each unique transcript was represented by a 
single probe set, except for 1 1  transcripts where there was 
no obvious ideal probe set. In these 11 cases 2 different 
probes sets were synthesized in situ representing different 
nucleotides of the same transcript. As controls the stand­
ard Affymetrix control set present on all Affymetrix expres­
sion arrays, consisting of quality control and alignment
controls as well as target preparation and hybridisation 
controls, was tiled. Since we did no t have a set of full- 
length housekeeping control genes of the marmoset for 
assessment of sample quality, scaling and/or normaliza­
tion of arrays, the species-specific control sets of rhesus 
monkey and hum an were tiled. In addition, both 5' and 3' 
sequences of 1 1  marmoset genes abundantly expressed in 
hippocampus were included as controls for assessing the 
overall labeling efficiency and quality of biotin-labeled 
target sample (Table 1).
The final design of the marmoset microarray consisted of 
a total of 1649 probe sets of which 97 control probe sets 
and 1552 probe sets representing 1541 different m arm o­
set transcripts. A total of 71 probe sets were derived from 
6 8  different sequences already available in GenBank, 
while the remaining 1481 probe sets were derived from 
1473 of our proprietary sequences obtained by sequenc­
ing marmoset ESTs. The majority (1445) of these 1473 
ESTs were derived from the set of 3215 ESTs that have 
been submitted to GenBank (Figure 1B). Another 28 ESTs 
had already been selected for representation on the mar­
moset array based on our initial annotation, bu t did not 
pass the criteria we applied for GenBank submission.
The majority of the ESTs represented on the marmoset 
array assigned with a gene symbol (in total 1251) could 
be classified according to gene ontology based on biolog­
ical function (1034) or molecular process (1106), repre­
senting a wide variety of different functional classes 
(Additional file 1).
Expression profiling o f  h ippocam pus and several non­
neuronal tissues
Detection rates, indicated by present calls, on RNA 
derived from hippocampus and cortex were high with 
85% present calls. Even though the sequences represented 
on the marmoset GeneChip are of hippocampal origin, 
detection rates on RNA derived from various peripheral 
tissues, including kidney, liver, adipose tissue, aorta, skel­
etal muscle, ovary and testis, were also high. All peripheral 
tissues tested so far displayed approximately 70% present 
calls, with the exception of adipose tissue that had an 
overall level of detection of 78% (Table 2).
Correlation coeffcients were calculated based on hybridi­
sation signals on the marmoset microarray for all possible 
combinations of tissues (Table 3). The highest correlation 
coefficient (0.96) was obtained when comparing gene 
expression in both neuronal tissues, i.e. hippocampus and 
cortex, indicating a high degree of similarity in expression 
profiles. In contrast, comparing hippocampal gene 
expression to all peripheral tissues resulted in a severe 
drop in correlation coefficient (Figure 2), ranging from
0.69 in muscle to 0.50 in liver.
A
B
ORF 24%
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T a b le  1: M a rm o se t-sp e c if ic  c o n t ro ls  on  th e  a rra y . A n  o v e rv ie w  o f  th e  m a rm o se t-sp e c if ic  c o n t ro ls  p re se n t on  th e  a rra y . T h e se  c o n tro ls  
re p re se n t tra n s c r ip ts  a b u n d a n tly  e xp re ssed  in h ip p o ca m p u s  and  p ro b e  sets f ro m  b o th  th e  3' and  th e  5' p a r t  o f  th e  tra n s c r ip t  w e re  
se le c ted  fo r  t i l in g  on  th e  a rra y , as in d ica te d  b y  th e  p ro b e  se t ID.
P ro b e  S e t  ID  G e n e  S y m b o l G e n e  T it le
ACTB -5_a t A C T B beta actin
A CTB -M _x_a t A C T B beta actin
A D D I-3 _ a t A D D I adducin 1 (alpha)
A D D I-5 _ a t A D D I adducin 1 (alpha)
A LD H 9 A I-3 _ a t A LD H 9 A I aldehyde dehydrogenase 9 family, member A l
A LD H 9A I-5_ s_a t A LD H 9 A I aldehyde dehydrogenase 9 family, member A l
C A M K IG -3 _ a t C A M K IG calcium calmodulin-dependent protein kinase IG
C A M K IG -5 _ a t C A M K IG calcium calmodulin-dependent protein kinase IG
CCT8-3_a t C C T 8 chaperonin containing T C P l,  subunit 8 (theta)
CCT8-5_s_at C C T 8 chaperonin containing T C P l,  subunit 8 (theta)
H D AC3-3_a t H D A C 3 histone deacetylase 3
H D AC3-5_s_at H D A C 3 histone deacetylase 3
LPL-3_at LPL lipoprotein lipase
LPL-5_at LPL lipoprotein lipase
LRPAPI-3_at LRPAPI low  density lipoprotein receptor-related protein associated
LRPAPI-5_s_at LRPAPI low  density lipoprotein receptor-related protein associated
PLD3-3_x_at PLD3 phospholipase D 3
PLD3-5_s_at PLD3 phospholipase D 3
UBE2G2-3_at UBE2G2 ubiquitin-conjugating enzyme E2G 2 (U B C 7  homolog, yeast)
UBE2G2-5_at UBE2G2 ubiquitin-conjugating enzyme E2G 2 (U B C 7  homolog, yeast)
ZAK-3_s_at Z A K sterile alpha m otif and leucine zipper containing kinase A Z K
ZAK-5_s_at Z A K sterile alpha m otif and leucine zipper containing kinase A Z K
Half of the probe sets of (767/1552 = 49.4%) were detect­
able (defined by a present call) in all tissues we tested so 
far, albeit in most cases at varying levels. Sorting of the 
expression profiles based on detection call allowed the 
identification of transcripts expressed exclusively in 1 of 
the 9 tissues tested. In liver, for example, we identified 7 
probe sets with a present or marginal call that had absent 
calls in the other 8  tissues tested. Three of these 7 probes 
sets represented cytochrome p-450, enzymes that mediate 
the oxidative biotransformation of most drugs and are 
known to be predominantly expressed in liver [14]. Detec­
tion of 5 probe sets was restricted to the kidney, one of 
which represented (prepro)renin. Renin is part of the 
renin-angiotensin system known to play a major role in 
volume regulation and is expressed at high levels in the 
kidney [15]. Sperm protein 17 was exclusively expressed 
in testis. An explanation for the fact that we find a number 
of genes that appear to be exclusively expressed in other 
tissues than brain, while the origin of the ESTs is brain tis­
sue, may be that these genes are predominantly derived 
from the list of 6 8  pre-existing GenBank sequences on the 
array, which are not necessarily expressed in brain. 
Indeed, this appears to be the case in many instances. For 
example, the 3 cytochrome p-450 probe sets exclusively 
expressed in liver are derived from pre-existing GenBank 
sequences, as well as 4 of the 5 kidney-specific probe sets 
(including renin) and 3 of the 4 testis-specific probe sets 
(including sperm protein 17). An additional explanation 
is that expression levels in brain may be too low to detect
using microarrays, but were detectable in our normalised 
cDNA library of hippocampus.
Detection of a total of 82 probe sets was restricted to neu­
ronal tissue (hippocampus and cortex) (Additional file 3). 
Among these 82 probe sets were several ion channels 
(KCNAB3, KCNF1, KCNH3, SCNla, CACNB1), neuro­
transmitter receptors (GABRA5, 5-HTR2C, GRIN1), neural 
cell adhesion molecules (NCAM, OPCML) and diverse 
components involved in neurotransmitter secretion 
(SYN2, SNPH), axonogenesis (SLITRK1) and neuro- 
trophic factor signalling (NTRK2). It must be noted that 
although the sequences have been annotated, the infor-
T a b le  2: D e te c t io n  ra te s  in  d if fe re n t t issues on  th e  m a rm o se t  
a rra y . T h e  p e rce n tag e  p re sen t, m a rg in a l and  ab se n t ca lls  
o b ta in e d  by  h yb r id is in g  th e  m a rm o se t  m ic ro a r ra y  w ith  R N A  
fro m  a  pane l o f  d if fe re n t t issues a re  ind ica ted .
T is s u e % p re s e n t % m a rg in a l % a b se n t
Hippocampus 84.8 0.9 I4.3
C o rte x 84.2 I.2 I4.6
Fat 78.4 I.I 20.5
A o rta 70.6 1.7 27.6
Ovary 70.2 1.4 28.3
Liver 69.5 1.3 29.2
Muscle 69.4 I 29.6
Kidney 69.3 I.3 29.4
Testis 68.I I.5 30.4
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T a b le  3: C o m p a r is o n  o f  gene  e xp re ss io n  be tw een  d iffe re n t tissues as d e te rm in e d  by h yb r id is a t io n  o f  th e  m a rm o se t  a rra y . T h e  Pea rson  
p ro d u c t m o m e n t c o rre la t io n  co e ff ic ie n t, r, is in d ica te d  fo r  th e  exp re ss ion  p ro f ile s  o f  a ll p o ss ib le  c o m b in a t io n s  o f  tissues f ro m  o u r  tissue  
panel.
H ip p o c a m p u s C o r t e x F a t A o r t a O v a ry L iv e r M u s c le K id n e y T e s t is
H ip p o c a m p u s 1 0.95741 0.60714 0.56866 0.54152 0.50381 0.68915 0.54918 0.53917
C o r t e x 1 0.62146 0.58074 0.54732 0.51323 0.6862 0.74907 0.56225
F a t 1 0.8834 0.822 0.78857 0.7828 0.82475 0.68859
A o r t a 1 0.81828 0.76857 0.78129 0.80429 0.67708
O v a ry 1 0.76293 0.74486 0.80561 0.70452
L iv e r 1 0.7282 0.80027 0.65683
M u sc le 1 0.74907 0.66837
K id n e y 1 0.69856
T e s t is 1
mation is not that detailed that for each gene the exact iso­
form or splice variant is indicated. For example, a closer 
look at the data of CACNB1 indicates that only isoform 1 
is targeted by our sequence, which indeed is expressed in 
brain, while isoform 2 is expressed in muscle. The users of 
the marmoset microarray have access to the exact probe 
set sequences as well as the EST sequences, allowing 
unambiguous determination of which part of the tran­
script is targeted and which splice variants or isoforms are 
detected.
Ninety probe sets were not detected in any of the tissues 
tested, which may be an intrinsic property of the selected 
probes or due to potential sequencing errors resulting in 
mismatches of the probe sets with the labeled mRNA 
(Additional file 3).
Discussion
We have constructed a marmoset-specific oligonucleotide 
microarray representing 1541 different marmoset tran­
scripts expressed in hippocampus. Although the 
sequences are primarily derived from a cDNA library of 
hippocampus, we have demonstrated that the marmoset 
array can also be efficiently used to characterise gene 
expression in other tissues of non-neuronal origin. The 
obtained detection rates are high, albeit somewhat lower 
in peripheral tissues than in neuronal tissue. The repro­
ducibility of hybridisation is high, judged by the correla­
tion (0.957) between both neuronal expression profiles 
(hippocampus and cortex). Moreover, the obtained tis­
sue-specific patterns of expression are in line with what 
can be expected, with neuronal genes expressed exclu­
sively in hippocampus and cortex, cytochrome p-450s in 
liver, preprorenin in kidney and sperm protein 17 in tes­
tis.
In the process of development of the marmoset micro­
array we have generated a set of 3215 marmoset 3' ESTs 
which have been submitted to GenBank. The number of 
marmoset sequences present today in publically available
sequence databases including GenBank are 1433 (query 
"callithrix jacobus" at the National Center for Biotechnol­
ogy Information [16]), which is a mix of working draft 
genomic sequence of the marmoset genome project, (par­
tial) mRNA sequences and ESTs and contains several 
redundancies. Our contribution of 3215 different 3' ESTs 
is a substantial expansion of the num ber of marmoset 
sequences. Both the marmoset array and the generated 
ESTs therefore significantly expand the available molecu­
lar tools for genetic analysis in this non-hum an primate 
animal model.
To our knowledge EUMAMA is the first DNA microarray 
specific for the common marmoset. As is the case with all 
first-generation microarrays for a species, some day in the 
future our marmoset microarray is likely to become obso­
lete and be replaced by an array targeting a larger part of 
the transcriptome. Until there is a better replacement (e.g 
when the marmoset genome is sequenced) this micro­
array is the only molecular tool allowing analysis of gene 
expression of a reasonably comprehensive number of 
genes expressed in marmoset brain. The strength of this 
array is no t only that it is species-specific, bu t also that 
there are corresponding marmoset sequences available for 
genetic follow-up of differentially expressed transcripts. 
So far the availability of microarrays specific for non­
hum an primates is very limited. Oligonucleotide microar­
rays for the rhesus macaque (Macaca mulatta) have 
recently become commercially available at both Affyme- 
trix and Agilent [17]. However, today expression profiling 
in non-hum an primates including chimpanzee (Pan trog­
lodytes), orangutan (Pongo pygmaeus), African green m on­
key (Chlorocebus aethiops), common marmoset (Callithrix 
jacchus) and cynomolgus monkeys (Macaca fascicularis) is 
still performed using hum an arrays [18-23], despite the 
fact that sequence mismatches affect hybridisation inten­
sity and likely result in a high level of false negatives or 
underrepresented expressed genes [18,24,25]. Interspecies 
use of microarrays is particularly problematic when using 
hum an microarrays to study gene expression in non-
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Hippocampus vs Cortex
Hippocampus
F igu re2
Sca tte rp lo ts  com paring  expression pro files o f d iffe rent tissues. Scatterplots of loglO-transformed signal intensities of 
several tissue comparisons showing the similarity of the expression profiles as indicated by the correlation coefficient.
hum an primates that are more divergent to humans than 
the great apes. While chimpanzee or orangutan have an 
average nucleotide sequence divergence of 0 .8 - 1 % and 
3% respectively [26-28], the average sequence divergence 
of hum an and rhesus macaque is approximately 5 % 
[29,30] increasing to 11% when comparing the marmoset 
and hum an genome [31]. A 4-8%  difference in sequence 
will cause each human-specific 2 5 -mer probe on a micro­
array to contain on average a single nucleotide mismatch 
with its target [32]. A large effect of sequence divergence 
on hybridisation signal was found in a study using a 
multi-primate cDNA array containing human, chimpan­
zee, orangutan and rhesus sequences, even between 
organisms that are only diverged ~1% [24]. The general 
picture that emerges is that the use of single species arrays 
for comparison between species may be problematic and 
yield spurious results [24], warranting careful data analy­
sis and a significant am ount of confirmatory analysis 
using other techniques. Meanwhile, the clear need for
generation of species-specific cDNA and oligonucleotide- 
based microarray resources remains [32].
Conclusion
In summary, we have generated the first marmoset-spe­
cific DNA microarray and demonstrated its use to charac­
terise large scale gene expression profiles of hippocampus 
but also of other neuronal and peripheral tissues. In addi­
tion, we have generated a large collection of ESTs of mar­
moset origin which are now available in the public 
domain. These new tools will facilitate molecular genetic 
research into this non-hum an primate animal model.
Methods
Generation o f  m arm oset cD N A  sequences
Total RNA was isolated from hippocampi of 5 adult mar­
mosets, both males and females ranging from 3 to 10 
years in age, After checking the quality of the isolated RNA 
it was pooled and used to construct a custom normalised
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cDNA library in pCMVSport6.1 (Invitrogen, Carlsbad, 
USA). For the development of the marmoset microarray a 
total of 23,300 clones were gridded in 61 384-well plates. 
In total approximately 5700 sequencing reactions were 
performed at Baseclear (Leiden, The Netherlands) using 
an anchored oligo-dT primer on 15 randomly selected 
384-well plates to generate partial 3' EST sequences.
R N A  preparation and labelling
Total RNA was isolated using TRIzol® reagent (Invitrogen 
Life Technologies, Carlsbad, CA, USA) according to the 
manufacturer's instructions. After isolation, total RNA was 
purified using the QIAGEN RNEasy® Mini Kit RNA 
Cleanup procedure (QIAGEN Inc., Valencia, CA, USA). 
RNA quality was assessed with the LabChip® RNA 6000 
Nano Assay on the 2100 Bioanalyzer (Agilent Technolo­
gies, Palo Alto, CA, USA). Per RNA sample, 5 |ig was used 
as input into the MessageAmp™ II-Biotin Enhanced Single 
Round aRNA Amplification Kit (AM1791, Ambion, Aus­
tin, USA) according to the manufacturer's instructions. 
Briefly, total RNA was converted to double-stranded 
cDNA followed by in vitro transcription to synthesize 
biotin-labeled aRNA. After purification the size distribu­
tion of the aRNA was checked with the LabChip® RNA 
6000 Nano Assay on the 2100 Bioanalyzer (Agilent Tech­
nologies) and the quantity was assessed by small sample 
spectophotometry on a Nanodrop ND-1000 Spectropho­
tometer (NanoDrop Technologies, Wilmington, Dela­
ware USA).
Hybridisations
The biotinylated aRNA was fragmented and 15 |ig was 
hybridised to marmoset arrays at the Leiden Genome 
Technology Center (LGTC®), Leiden University, The Neth­
erlands, according to the manufacturer's recommenda­
tions (Affymetrix, Santa Clara, USA).
Data analysis
Affymetrix GeneChip® Operating Software (GCOS) was 
used to estimate signal intensities plus signal reliabilities. 
Data was median normalized in excel and subsequently 
scatterplots were constructed and correlation coefficients 
calculated using R version 2.2.0 [33]. Probe sets assigned 
with a gene symbol were functionally classified according 
to biological process and molecular function using 
Netaffx Analysis Center [34].
M a p p in g  and annotation o f  EST sequences
In order to obtain high-quality data the EST sequences 
were trimmed before further analysis. At the 3' end, at 
least 15% of each sequence was removed so that final 
DNA fragment lengths were 700 bases. In addition, 20 
bases from the 5' end of the EST sequences were trimmed. 
For the annotation of the EST dataset, the sequences were 
reverse complemented and compared to the RefSeq data­
set of hum an genes (NCBI Refseq build 36.1) using a 
locally installed version of the Blat software [35]. Remain­
ing sequences that could not be unambiguously assigned 
to a gene name were mapped to the hum an genome 
sequence (NCBI Refseq assembly version 36.1) according 
to the standard parameters of the software. ESTs with a hit 
on the genome were annotated with the gene name of the 
gene which is located at the respective chromosome 
region. Ambiguities, e.g. if an EST sequence covered more 
than one gene, were resolved manually. Finally, a Blat 
search with increasing sensitivity parameters was per­
formed to map ESTs across species.
The annotation procedure described above allowed a reli­
able annotation of EST data even if sequencing errors 
would cause frame-shifts in coding regions. In order to 
annotate open reading frames (ORFs) associated with the 
ESTs, ORFs with a length of at least 100 bases starting 
from the 5' end of the reverse complementary sequences 
were extracted. The translated amino acid sequences were 
mapped against the hum an protein sequences from Uni- 
Prot (Release 50 of May 2006, [36]) using Blat [35]. All 
sequences without any hit on a protein sequence starting 
at the first position ofthe 5' end where rejected. The 
remaining candidate ORFs were first validated by a com­
parison of the gene names from the UniProt hits to the 
gene names of the above determined RefSeq hits. To be 
included as bona fide ORFs, the translated ORF sequences 
had to fulfil an additional criterion. The length of the pep­
tide sequences derived from the ESTs had to cover at least 
80% of the peptide sequence length which can be 
expected from the corresponding part of the protein 
sequence from UniProt.
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